Ofichem Consolidates CDMO & Pharma Brands Under Single Ofichem Identity

European CDMO and pharmaceutical supplier Ofichem has unified its portfolio of brands—including Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala and Avivia—under a single Ofichem trading name, effective April 1.

The consolidation brings together the group’s capabilities across API, drug substance, drug product, and sourcing and distribution into one integrated offering, aimed at simplifying engagement for pharmaceutical and biotech customers seeking fewer, more comprehensive partners. Ofichem said the move improves visibility into its end‑to‑end capabilities without changing its operational focus or service quality.

The company added that the unified structure strengthens its position as a European‑based CDMO, supporting regulatory expertise, supply chain reliability and closer collaboration amid growing industry emphasis on security and transparency.